Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CEE NASDAQ:IMG TSE:OLA NASDAQ:TXG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCEEThe Central and Eastern Europe Fund$15.54+0.9%$15.40$9.82▼$17.11N/A1.2143,777 shs19,098 shsIMGCIMG$0.28+2.8%$0.39$0.23▼$8.00$10.03M1.36932,676 shs344,928 shsOLAOrla MiningC$15.67-2.9%C$14.40C$4.60▼C$16.98C$3.55B1.57615,532 shs406,991 shsTXG10x Genomics$12.45+0.6%$10.46$6.78▼$24.76$1.53B2.032.71 million shs2.08 million shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCEEThe Central and Eastern Europe Fund-0.12%-2.59%-0.10%+11.88%+37.82%IMGCIMG+3.80%-4.96%-24.51%-56.98%+26,799,900.00%OLAOrla Mining-0.37%+10.40%+2.80%+3.40%+182.66%TXG10x Genomics+1.23%+2.23%+12.35%+64.71%-38.15%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCEEThe Central and Eastern Europe FundN/AN/AN/AN/AN/AN/AN/AN/AIMGCIMGN/AN/AN/AN/AN/AN/AN/AN/AOLAOrla Mining0.7414 of 5 stars1.50.01.70.00.63.30.0TXG10x Genomics4.4754 of 5 stars3.24.00.04.82.62.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCEEThe Central and Eastern Europe Fund 0.00N/AN/AN/AIMGCIMG 0.00N/AN/AN/AOLAOrla Mining 3.00BuyC$14.82-5.42% DownsideTXG10x Genomics 2.46Hold$14.1313.45% UpsideCurrent Analyst Ratings BreakdownLatest IMG, OLA, TXG, and CEE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/12/2025TXG10x GenomicsWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E+)6/27/2025TXG10x GenomicsWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E+)6/26/2025TXG10x GenomicsBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$12.00 ➝ $13.006/24/2025TXG10x GenomicsBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$12.00 ➝ $13.006/11/2025TXG10x GenomicsWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E+)6/4/2025OLAOrla MiningRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetC$15.00 ➝ C$18.005/24/2025TXG10x GenomicsWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell (E+) ➝ Sell (E+)5/19/2025TXG10x GenomicsMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$26.00 ➝ $18.005/15/2025TXG10x GenomicsStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$14.00 ➝ $14.005/13/2025TXG10x GenomicsUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$14.00 ➝ $12.005/12/2025TXG10x GenomicsThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetSell ➝ Sell$7.50 ➝ $6.50(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCEEThe Central and Eastern Europe FundN/AN/AN/AN/AN/AN/AIMGCIMG$3.35M2.99N/AN/A$1.39 per share0.20OLAOrla MiningC$236.97M14.98C$0.88 per share17.84C$1.49 per share10.53TXG10x Genomics$624.66M2.45N/AN/A$5.81 per share2.14Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCEEThe Central and Eastern Europe FundN/AN/A0.00∞N/AN/AN/AN/AN/AIMGCIMG-$8.75M-$7.37N/A∞N/AN/AN/AN/A7/22/2025 (Estimated)OLAOrla MiningC$7.47MC$0.05334.93∞N/A3.15%2.24%4.26%N/ATXG10x Genomics-$182.63M-$1.30N/AN/AN/A-25.14%-23.22%-18.02%8/6/2025 (Estimated)Latest IMG, OLA, TXG, and CEE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025TXG10x Genomics-$0.35N/AN/AN/A$139.36 millionN/A5/8/2025Q1 2025TXG10x Genomics-$0.45-$0.36+$0.09-$0.28$131.91 million$154.88 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCEEThe Central and Eastern Europe Fund$0.352.25%N/AN/AN/AIMGCIMGN/AN/AN/AN/AN/AOLAOrla MiningN/A18.91%N/AN/AN/ATXG10x GenomicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCEEThe Central and Eastern Europe FundN/AN/AN/AIMGCIMGN/AN/AN/AOLAOrla Mining12.684.541.22TXG10x GenomicsN/A5.374.68Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCEEThe Central and Eastern Europe Fund34.41%IMGCIMG23.42%OLAOrla Mining47.88%TXG10x Genomics84.68%Insider OwnershipCompanyInsider OwnershipCEEThe Central and Eastern Europe Fund0.11%IMGCIMG0.12%OLAOrla Mining51.68%TXG10x Genomics9.39%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCEEThe Central and Eastern Europe FundN/AN/AN/ANot OptionableIMGCIMG3336.40 million36.35 millionN/AOLAOrla Mining327226.58 millionN/ANot OptionableTXG10x Genomics1,240123.13 million111.57 millionOptionableIMG, OLA, TXG, and CEE HeadlinesRecent News About These Companies10x Genomics Inc (TXG) and A*STAR GIS Collaborate on TISHUMAP Study | TXG stock newsJuly 17 at 10:14 AM | gurufocus.com10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target DiscoveryJuly 17 at 9:00 AM | prnewswire.com3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff RiskJuly 15 at 10:20 AM | zacks.comWeiss Ratings Reiterates Sell (E+) Rating for 10x Genomics (NASDAQ:TXG)July 14 at 2:28 AM | marketbeat.com10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025July 10, 2025 | prnewswire.com10x Genomics (NASDAQ:TXG) Trading Down 6.1% - What's Next?July 7, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Shares Purchased by Summit Trail Advisors LLCJuly 3, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Sells 350,118 Shares of 10x Genomics (NASDAQ:TXG)July 2, 2025 | marketbeat.comDiversified Trust Co Boosts Holdings in 10x Genomics (NASDAQ:TXG)July 1, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Rating Lowered to Hold at Wall Street ZenJune 28, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Given Sell (E+) Rating at Weiss RatingsJune 28, 2025 | marketbeat.comTXG - 10x Genomics Inc Ordinary Shares - Class A Chart - MorningstarJune 27, 2025 | morningstar.comMBank of America Forecasts Strong Price Appreciation for 10x Genomics (NASDAQ:TXG) StockJune 26, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Trading Up 7.3% Following Analyst UpgradeJune 25, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Given New $13.00 Price Target at BarclaysJune 24, 2025 | marketbeat.com10x Genomics (NASDAQ:TXG) Given Average Rating of "Hold" by AnalystsJune 24, 2025 | marketbeat.com10x Genomics: Stuck In NeutralJune 23, 2025 | seekingalpha.com10x Genomics Settles Patent Dispute With BrukerJune 23, 2025 | insidermonkey.comGAMMA Investing LLC Has $273,000 Holdings in 10x Genomics (NASDAQ:TXG)June 22, 2025 | marketbeat.comDelta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To KnowJune 17, 2025 | msn.comBrown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental ConcernsJune 10, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesThe Boring Is Beautiful Portfolio: 3 Stocks for a Worried WorldBy Jeffrey Neal Johnson | June 22, 2025View The Boring Is Beautiful Portfolio: 3 Stocks for a Worried WorldThese 3 Dividend Stocks Are Not Concerned With Tariff NoiseBy Thomas Hughes | July 11, 2025View These 3 Dividend Stocks Are Not Concerned With Tariff NoisePalantir’s $100M Nuclear OS Pact Boosts Bullish CaseBy Chris Markoch | July 1, 2025View Palantir’s $100M Nuclear OS Pact Boosts Bullish Case3 Utility Stocks That Combine Income and StabilityBy Chris Markoch | July 2, 2025View 3 Utility Stocks That Combine Income and StabilityValue vs Growth Ratio Hits Cycle Low—Top Value Picks to BuyBy Gabriel Osorio-Mazilli | June 30, 2025View Value vs Growth Ratio Hits Cycle Low—Top Value Picks to BuyIMG, OLA, TXG, and CEE Company DescriptionsThe Central and Eastern Europe Fund NYSE:CEE$15.54 +0.13 (+0.85%) Closing price 03:55 PM EasternExtended Trading$15.55 +0.01 (+0.06%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Central and Eastern Europe Fund, Inc. is a closed ended equity mutual fund launched by Deutsche Investment Management Americas Inc. The fund is managed by Deutsche Asset Management International GmbH. It invests in the public equity markets across Central and Eastern Europe. The fund seeks to invest in stocks of companies operating across diversified sectors. It benchmarks the performance of its portfolio against the CECE, RTX, and ISE National 30. The fund was formerly known as The Central Europe And Russia Fund, Inc. The Central and Eastern Europe Fund, Inc. was formed on March 6, 1990 and is domiciled in the United States.CIMG NASDAQ:IMG$0.28 +0.01 (+2.76%) As of 04:00 PM EasternCIMG Inc. is a digital marketing, sales and distribution company for various consumer products with focuses on food and beverages. CIMG Inc., formerly known as NUZEE INC., is based in BEIJING.Orla Mining TSE:OLAC$15.67 -0.47 (-2.91%) As of 04:00 PM EasternOrla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds two gold projects; the Camino Rojo gold and silver project in Zacatecas State, Mexico, and the Cerro Quema gold project in Panama. It conducts business activities in the geographic areas of Mexico, Panama, the United States, and Canada.10x Genomics NASDAQ:TXG$12.45 +0.08 (+0.65%) Closing price 04:00 PM EasternExtended Trading$12.45 0.00 (0.00%) As of 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now Citigroup Earnings Could Signal What’s Next for Markets This ASML Dip Could Be Gone Before You Know It—Don’t Miss Out Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.